VAR2CSA-Mediated Host Defense Evasion of Infected Erythrocytes in Placental Malaria
Overview
Affiliations
Over 30 million women living in endemic areas are at risk of developing malaria during pregnancy every year. Placental malaria is characterized by massive accumulation of infected erythrocytes in the intervillous space of the placenta, accompanied by infiltration of immune cells, particularly monocytes. The consequent local inflammation and the obstruction of the maternofetal exchanges can lead to severe clinical outcomes for both mother and child. Even if protection against the disease can gradually be acquired following successive pregnancies, the malaria parasite has developed a large panel of evasion mechanisms to escape from host defense mechanisms and manipulate the immune system to its advantage. Infected erythrocytes isolated from placentas of women suffering from placental malaria present a unique phenotype and express the pregnancy-specific variant VAR2CSA of the Erythrocyte Membrane Protein (PfEMP1) family at their surface. The polymorphic VAR2CSA protein is able to mediate the interaction of infected erythrocytes with a variety of host cells including placental syncytiotrophoblasts and leukocytes but also with components of the immune system such as non-specific IgM. This review summarizes the described VAR2CSA-mediated host defense evasion mechanisms employed by the parasite during placental malaria to ensure its survival and persistence.
Evasive mechanisms of human VSG and PfEMP1 antigens with link to Vaccine scenario: a review.
Obi O, Obiezue R, Eze D, Adebote D J Parasit Dis. 2025; 49(1):13-28.
PMID: 39975623 PMC: 11833005. DOI: 10.1007/s12639-024-01740-9.
Multi-System Dysregulation in Placental Malaria Contributes to Adverse Perinatal Outcomes in Mice.
Ekregbesi P, Seibert B, Parish M, Flores-Garcia Y, Creisher P, Hoffmann J bioRxiv. 2025; .
PMID: 39868257 PMC: 11761038. DOI: 10.1101/2025.01.15.633265.
Dorin-Semblat D, Semblat J, Hamelin R, Srivastava A, Tetard M, Matesic G PLoS Pathog. 2025; 21(1):e1012861.
PMID: 39804934 PMC: 11761665. DOI: 10.1371/journal.ppat.1012861.
Ma R, Salinas N, Orr-Gonzalez S, Richardson B, Ouahes T, Torano H PLoS Pathog. 2024; 20(3):e1011879.
PMID: 38437239 PMC: 10939253. DOI: 10.1371/journal.ppat.1011879.
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for .
Takashima E, Otsuki H, Morita M, Ito D, Nagaoka H, Yuguchi T Biomolecules. 2024; 14(1).
PMID: 38254700 PMC: 10813614. DOI: 10.3390/biom14010100.